Header
Future Science Group Publishing Solutions
1 Section Header
2 For more information visit www.future-science-group.com Contents
Page
Our Journal Portfolio 2 ......
Future Medicine At-A-Glance 3 ......
Future Science and Newlands Press At-A-Glance 4 ......
Publishing Solutions 5
• Open Access 7
• Accelerated Publication 7
• Social Media Sharing 8
• Digital Enhancements 9
• Video Journal of Biomedicine 10
• Plain Language Summaries of Publications 11
• Webinars 11
• Host on an FSG Specialist Website 12 ......
PharmaPlatforms 13 ......
1 Our Journal Portfolio Our Journal Portfolio
Future Science Group (FSG) is an independent publisher, based in London, with an expanding and diverse group of journals in cutting-edge areas of postgenomic scientific and medical information. FSG houses three imprints; Future Medicine, Future Science and Newlands Press. All journals are peer reviewed and many are also indexed on MEDLINE, Clarivate’s Science Citation Index Expanded and Emerging Sources Citation Index, EMBASE, Chemical Abstracts, DOAJ, PubMed Central and Scopus. We also offer DRM-free perpetual access to a wide variety of eBook collections.
ALL PUBLICATIONS ARE:
ORIGINAL AND TIMELY Blending commissioned and unsolicited content, including reviews, research and commentaries, to ensure that readers are kept comprehensively up-to-date with the latest advances and techniques in bioscience and clinical practice, whatever their discipline.
SUPPORTED BY STRONG EDITORIAL STANDARDS All journals are underpinned by robust double-blind peer review ensuring only articles of the highest quality are published. Authors benefit from a supportive in-house editorial team, taking them from pre-submission enquiries, right through to publication and beyond.
VISIBLE AND ACCESSIBLE GLOBALLY To ensure 24/7 access and maximum discoverability, all of our titles are hosted by Atypon on industry-leading websites.
2 For more information visit www.future-science-group.com Future Medicine At-A-Glance
FUTURE MEDICINE AT-A-GLANCE
Journal MEDLINE- Impact factor Frequency Launch indexed (2018) year Bioelectronics in Medicine No n/a 4 2018
Biomarkers in Medicine Yes 2.268 18 2007
Breast Cancer Management No n/a Rolling 2012
CNS Oncology Yes n/a Rolling 2012
Colorectal Cancer No n/a Rolling 2012
Concussion PMC-indexed n/a Rolling 2015
Epigenomics Yes 4.404 24 2009
Future Cardiology Yes n/a 6 2005
Future Microbiology Yes 2.746 18 2006
Future Neurology No n/a Rolling 2006
Future Oncology Yes 2.279 36 2005
Future Virology No 0.730 12 2006
Hepatic Oncology PMC-indexed n/a Rolling 2014
Immunotherapy Yes 3.028 18 2009
International Journal of Endocrine Oncology No n/a Rolling 2014
International Journal of Hematologic Oncology PMC-indexed n/a Rolling 2012
Journal of 3D Printing in Medicine No n/a 4 2017
Journal of Comparative Effectiveness Research Yes 1.485 18 2012
Lung Cancer Management PMC-indexed n/a Rolling 2012
Melanoma Management PMC-indexed n/a Rolling 2014
Nanomedicine Yes 4.717 30 2006
Neurodegenerative Disease Management Yes n/a 6 2011
Pain Management Yes n/a 6 2011
Personalized Medicine Yes 1.414 6 2004
Pharmacogenomics Yes 2.265 18 2000
Regenerative Medicine Yes 2.383 12 2006
: Open access; PMC: PubMed Central.
3 SectionFuture Science Header and Newlands Press At-A-GlanceFuture Science
FUTURE SCIENCE AND NEWLANDS PRESS AT-A-GLANCE
Journal MEDLINE- Impact factor Frequency Launch indexed (2018) year Bioanalysis Yes 2.321 24 2009
BioTechniques Yes 1.659 12 1983
Future Drug Discovery No n/a Quarterly 2019
Future Medicinal Chemistry Yes 3.617 24 2009
Future Science OA PMC-indexed n/a Rolling 2015
International Journal of Pharmacokinetics No n/a 4 2016
Pharmaceutical Patent Analyst Yes n/a 6 2012
Therapeutic Delivery Yes n/a 12 2010
: Open access; PMC: PubMed Central.
4 For more information visit www.future-science-group.com Publishing Solutions
COMPREHENSIVE COVERAGE
Whether you’re looking to publish clinical trial results, describe the design of a new study or provide an in-depth review, our team will support you fully before, during and after publication. We are happy to work with both academic and industry authors, as our goal is to work with the leading specialty experts across all organizations. In addition to offering presubmission advice, we will assist you with journal selection for a broad range of article types, including:
ORIGINAL RESEARCH REVIEWS • Pre- and post-registration studies • Narrative reviews • Comparative effectiveness research • Systematic reviews • Observational studies • Unmet medical needs • Clinical trial protocols and • Multidisciplinary approaches to care methodologies • Consensus and treatment • Cost-effectiveness/HEOR studies guidelines • Negative data • Management perspectives • Evidence-based medicine • Therapeutic overviews and real-world data • Drug, device and vaccine • Meta-analyses evaluations • Patient-reported outcomes • Commentaries on key clinical studies
5 Publishing Solutions
PUBLISHING SOLUTIONS All FSG journals offer a number of options to ensure each article is published in a timely, accessible manner, engages the reader and reaches a broad audience.
6 For more information visit www.future-science-group.com Institutional Trials Publishing Solutions
OPEN ACCESS
All FSG journals provide a range of options to make articles freely accessible online. Our subscription journals offer an Open Access option, where articles are made free to read under a CC BY-NC-ND license. Certain articles are excluded from this (such as Drug Evaluation and Device Evaluation articles) and for these articles we offer a Sponsored Access option. We also offer reduced Open Access fees for articles 12 months after publication. Third parties are allowed to support Open Access fees, provided they have been involved with the development of the paper from the outset.
FSG also publishes 13 fully Open Access journals, with all articles requiring payment of the Open Access fee on acceptance for publication.
Sponsors or third parties wishing to make an article free to download from our website, for use on a commercial basis, can provide access by paying the appropriate Sponsored Access fee. More information on the Sponsored Access option is available upon request.
ACCELERATED PUBLICATION
u mission Our typical publication times from submission to acceptance are ~16
ee PEER weeks as standard (subject to peer REVIEW review). However, if you require earlier publication, or by a specific date, you can ee publish in as little as 6 weeks through our Accelerated Publication service.
ee Accelerated Publication could help you stay ahead of the field, or allow you to get some AUTHOR REVISION ee vital content out to coincide with a conference or meeting. It will maximize the impact of your scientific ee PRODUCTION endeavour, ensuring swifter access to your latest findings. A fee per published page AUTHOR APPROVAL n ine applies, and publication is, of course, still u ication subject to independent peer review.
7 Publishing Solutions
SOCIAL MEDIA REACH
It has been said that physicians globally spend at least 1.5 hours online per day conducting research, with at least half of that on social media. Therefore sharing the news that an article has been published via social media is a great way to keep interested readers informed about your work.
All FSG journals are active on social media, including Twitter, Facebook and LinkedIn, sharing articles when published. Posts are tailored to ensure the greatest discoverability of articles, with images and videos used as well as #hashtags and @mentions where relevant. All articles also include sharing links at the top of the page, making it easy for authors and readers alike to create posts for articles.
All conversations surrounding articles are measured and can be viewed via the Altmetric score displayed on the article homepage.
We can also offer extended reach via social media, offering options to increase the audience for articles and reach a specific reader demographic.
Details of this option are available upon request.
8 Institutional Trials Publishing Solutions
DIGITAL ENHANCEMENTS
VIDEOS AND VIDEO ABSTRACTS
Time-constrained physicians are now spending more and more time watching video content for professional purposes. Videos enhance publications by allowing authors to explain their work in a way that the print article or a static figure cannot. All our journals can feature a range of videos, including ey trend in L video abstracts, mechanism of action videos, videos of In hat area of application do you u e L procedures, and more.
inica Video abstracts summarizing an article enable readers to hat do you in e ti ate u in L iscover armaceutica easily understand the findings of this work in an engaging rug manner. They can be in a variety of formats, such as an Forensic target or iomar er author discussing their paper on camera or an animated afet assessment t er series of slides/images. We are able to offer a number of hat do you u e L for rug recision me icine options, including, for a fee, adding figures or slides or even
creating a video from scratch. hat molecule do you analy e u in L
mo ecu e arge ana sis Further details are available upon request. erapeutic proteins ot ma onoc ona anti o ies mo ecu e ana sis rotein iomar ers n ogenous ana tes hat type of matrix do you or mainly ith GRAPHICAL ABSTRACTS AND eutra i ing anti o ies INFOGRAPHICS epti es Fusion proteins
Graphical abstracts provide a concise, nti o rug con ugates s asma visual summary of the main findings of igonuc eoti es
o e t er an article. If required, we can provide a oo range of design support services, from polishing an existing figure to creating a bespoke graphical abstract from a issue omogeni ations i ute handdrawn figure. w o e oo Faeces rie oo Infographics go beyond the graphical abstract and provide erum spots
a more in-depth overview of the information presented in rine
an article. These are particularly useful if summarizing a F hat are the main challen e in u in L for large volume of information, for instance in a Clinical Trial lar e molecule analy i t er
Protocol article. Again we can offer a full range of design atri interference and creation services. namic range hat are the main limitation of roug put L hen employed in lar e molecule analy e amp e vo ume imite se ectivit recision imite mu tip e ing options ensitivit Requires specific antibodies 51% eagent avai a i it For more information visit www.future-science-group.com ost 9 Lack of specificity 37% eagent eve opment can t er e time-consuming
atri interferences
ritica reagent consistenc an met o performance consistenc
hat i an accepta le lot-to-lot aria ility of ample concentration in your la
L re ulation
cceptance u ed for ample re-a ayed in incurred ample re-analy i
≤30% ≤20% In total of re pondent or in ot current oth re ulated and performe t er non-re ulated ioanaly i compared to 2 and 1 egu ate or in olely in on-regu ate hat acceptance criteria do you u e forre ulated tandard and and in L non-re ulated re pecti ely
ot F
tan ar criteria ase on regu ator gui ance for a samp es e cept he future of L for for
a your u e of L chan ed o er the la t year
es
o
ta e t e same In the next year do you thin the percenta e2 of L tudie ill ncrease 0 ecrease 2 ta t e same 1
out the re pondent
Location
ort merica
out merica urope
sia r ani ation
ca emic ceania
Jo title iotec no og emist cientist overnment researc irector
arge p arma anager roup ea er
ma i -si e tu ent p arma
ec nician uipment ven or t er t er Publishing Solutions
VIDEO JOURNAL OF BIOMEDICINE
The Video Journal of Biomedicine provides readers with short, high-quality, interview-style videos with authors discussing their latest published, peer-reviewed paper from any journal worldwide. All videos are professionally filmed, produced by our in-house team and published open access on a dedicated platform. Each video provides the opportunity for authors to personally discuss their latest published work in more detail; highlighting its importance to the field, placing it in context, and discussing future implications.
More information is available at: www.biomedicine.video
10 For more information visit www.future-science-group.com Publishing Header Solutions
PLAIN LANGUAGE SUMMARIES OF PUBLICATIONS
Recognising the importance of making relevant scientific literature understandable for patients, FSG is developing a new article type within our journals: Plain Language Summaries of Publications (PLSP). These are short, 2–3-page, visually enriched articles published in our journals that provide a summary of a key publication from any journal published worldwide. The audience for PLSP will consist of patients and the general public. They are also intended to be read by nonspecialist clinicians, research scientists, decision- makers and a range of professionals in the healthcare community looking to gain an understanding of the research presented.
Further details and guidelines on submitting a PLSP are available at www.futuremedicine.com/authorguide
WEBINARS
FSG has an in-house team dedicated to providing webinars across all therapeutic areas. Our team can work with the authors of an article to create an online presentation and a Q&A session that helps the audience learn about the article content, serving as a tool to provide depth to your work and educate your audience.
11 Specialist Website
HOST ON AN FSG SPECIALIST WEBSITE
Complementing our journal content, FSG publishes nine specialist websites, which enable professionals to keep up-to-date and easily connect and collaborate with their peers in niche scientific fields. Enriched with high-value expert insight and integration with social media, our sites provide a route to further broadcast content published in our associated journals. These specialist websites are membership based, ensuring all communications from the site are fully compliant, however anyone with an interest in the field can sign up free of charge. For a fee, articles can be hosted on the relevant site and made exclusively accessible to members through sharing on social media and featuring the article in the weekly members’ newsletter.
3DMedNet Covering 3D printing and bioprinting in medicine and healthcare Neuro Central www.3dmednet.com Uniting all aspects of neurology and neuroscience Publish in a time an accessi e manner PUBLISH Bioanalysis Zone www.neuro-central.com Market-leading online resource for the global bioanalytical community Oncology Central www.bioanalysis-zone.com Delivering the latest news and insights Enrich t e information presente in the fast-moving field of oncology ENRICH BioTechniques www.oncology-central.com The latest methods, techniques and protocols for the life science research community RegMedNet Reach a broad, scientific and medical professional The latest research on all regenerative www.biotechniques.com au ience e medicine topics from stem cells to REACH Evidenceregenerative pharmaceuticals The Evidence Base BaseTM www.regmednet.com Covering the latest news, opinion and insight into the collection and application of real-world data to real-world problems RxNet www.evidencebaseonline.com Uniting scientists from the fieldsNet of Engage wit t e rea er an our au ience chemistry, biochemistry and beyond to further the ever-booming industry ENGAGE Infectious Diseases Hub of drug discovery and development Covering all aspects of medical www.rx-network.com microbiology, from bench to bedside www.id-hub.com
12 For more information visit www.future-science-group.com Pharmaplatforms Header
PHARMAPLATFORMS
armaPlatforms
PharmaPlatforms is the creative arm of FSG, building comprehensive, collaborative communication plans around published content and scientific information. By providing a range of platforms and solutions, we enable timely and accessible publication that enriches the information presented, engages the reader, and reaches a broad, scientific and medical professional audience.
Publish in a time an accessi e manner PUBLISH
Enrich t e information presente
ENRICH
Reach a broad, scientific and medical professional au ience REACH
Engage wit t e rea er an our au ience
ENGAGE
Find out more at: www.pharmaplatforms.com
13 CONTACT US
Joanne Walker Head of Publishing Solutions
+44(0)20 8371 6090 [email protected] @JoWFSG
Future Science Group Unitec House 2 Albert Place London, N3 1QB United Kingdom
@futuresciencegp future-science-group Future Science Group www.future-science-group.com
14 For more information visit www.future-science-group.com